DHR:NYE-Danaher Corporation (USD)

EQUITY | Diagnostics & Research | New York Stock Exchange

Last Closing

USD 228.55

Change

0.00 (0.00)%

Market Cap

USD 54.15B

Volume

7.03M

Analyst Target

USD 220.40
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Danaher Corp designs, manufactures & markets professional, medical, industrial & commercial products.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-22 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
A Agilent Technologies Inc

+0.09 (+0.07%)

USD 40.09B
IQV IQVIA Holdings Inc

+1.84 (+0.93%)

USD 36.13B
LH Laboratory Corporation of Amer..

-0.77 (-0.34%)

USD 19.12B
DGX Quest Diagnostics Incorporated

-0.16 (-0.10%)

USD 17.09B
QGEN Qiagen NV

+0.15 (+0.34%)

USD 10.26B
CRL Charles River Laboratories

-0.38 (-0.20%)

USD 9.50B
VNRX Volitionrx Ltd

-0.07 (-9.75%)

USD 0.06B
ENZ Enzo Biochem Inc

-0.02 (-2.85%)

USD 0.04B
TMO Thermo Fisher Scientific Inc

+1.24 (+0.24%)

N/A
MTD Mettler-Toledo International I..

+3.65 (+0.30%)

N/A

ETFs Containing DHR

AILG 6.99 % 0.00 %

N/A

N/A
SYNB Putnam Biorevolution ETF 6.29 % 0.00 %

+0.26 (+0.04%)

USD 5.36M
DXSF:XETRA Xtrackers - Stoxx Europe .. 5.91 % 0.00 %

+0.03 (+0.04%)

USD 0.08B
LIFE-U:CA Evolve Global Healthcare .. 5.53 % 0.00 %

+0.12 (+0.04%)

N/A
ZWHC:CA BMO Covered Call Health C.. 4.69 % 0.00 %

+0.25 (+0.04%)

N/A
BCHP 4.47 % 0.00 %

N/A

N/A
XDG3:XETRA Xtrackers MSCI Global SDG.. 4.45 % 0.00 %

-0.02 (0.04%)

USD 0.14B
XGEN:XETRA Xtrackers MSCI Genomic He.. 4.34 % 0.00 %

-0.14 (0.04%)

N/A
WHCS:SW iShares MSCI World Health.. 4.21 % 0.00 %

N/A

N/A
YALL God Bless America ETF 4.17 % 0.00 %

+0.03 (+0.04%)

N/A
XGES:LSE Xtrackers MSCI Genomic He.. 4.11 % 0.00 %

-0.01 (0.04%)

N/A
CBUF:F iShares V Public Limited .. 4.06 % 0.00 %

+0.04 (+0.04%)

N/A
SANE 3.95 % 0.00 %

N/A

N/A
GDOC Goldman Sachs ETF Trust 3.52 % 0.00 %

+0.30 (+0.04%)

USD 0.02B
XUHC:SW 3.16 % 0.00 %

N/A

N/A
IUHC:SW iShares S&P 500 Health Ca.. 3.06 % 0.00 %

+0.12 (+0.04%)

N/A
GXLV:LSE SPDR® S&P® U.S. Health .. 3.06 % 0.00 %

-0.05 (0.04%)

N/A
XLV Health Care Select Sector.. 2.92 % 0.13 %

+0.75 (+0.04%)

USD 36.67B
QDVG:XETRA iShares S&P 500 Health Ca.. 2.90 % 0.00 %

-0.05 (0.04%)

USD 2.05B
SXLV:SW SPDR S&P U.S. Health Care.. 2.86 % 0.00 %

+0.07 (+0.04%)

N/A
ZPDH:F SPDR S&P U.S. Health Care.. 2.85 % 0.00 %

+0.06 (+0.04%)

USD 0.40B
ZPDH:XETRA SPDR S&P U.S. Health Care.. 2.85 % 0.00 %

-0.19 (0.04%)

USD 0.40B
XSHC:LSE Xtrackers MSCI USA Health.. 2.85 % 0.00 %

-3.50 (0.04%)

USD 0.61B
XUHC:LSE Xtrackers MSCI USA Health.. 2.85 % 0.00 %

-0.38 (0.04%)

USD 0.61B
CNEQ The Alger ETF Trust 2.83 % 0.00 %

+0.41 (+0.04%)

N/A
XUHC:F Xtrackers (IE) Public Lim.. 2.79 % 0.00 %

+0.55 (+0.04%)

USD 0.85B
XUHC:XETRA Xtrackers MSCI USA Health.. 2.79 % 0.00 %

-0.23 (0.04%)

USD 0.85B
INNO Harbor Disruptive Innovat.. 2.76 % 0.00 %

N/A

N/A
BKDV BNY Mellon ETF Trust II 2.70 % 0.00 %

+0.01 (+0.04%)

USD 0.01B
CURE Direxion Daily Healthcare.. 2.59 % 1.06 %

+2.58 (+0.04%)

USD 0.17B
FHLC Fidelity® MSCI Health Ca.. 2.54 % 0.08 %

+0.65 (+0.04%)

USD 2.62B
WEBD:XETRA AETF-MUSCNZAP EOA ETF 2.50 % 0.00 %

-0.52 (0.04%)

N/A
USRI:LSE 2.50 % 0.00 %

N/A

N/A
UPVLD:SW 2.35 % 0.00 %

N/A

N/A
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.30 % 0.00 %

-0.05 (0.04%)

N/A
XAMB:F Amundi Index Solutions - .. 1.53 % 0.00 %

+0.14 (+0.04%)

N/A
HYLG Global X Funds - Global X.. 1.44 % 0.00 %

+0.15 (+0.04%)

N/A
LESW:LSE 1.38 % 0.00 %

N/A

N/A
WSRI:LSE 1.30 % 0.00 %

N/A

N/A
WELB:XETRA Amundi MSCI ACWI SRI PAB .. 1.08 % 0.00 %

-0.06 (0.04%)

N/A
RAVI FlexShares Ready Access V.. 0.86 % 0.25 %

N/A

USD 1.15B
CWW.A:CA 0.00 % 1.49 %

N/A

N/A
IXJ iShares Global Healthcare.. 0.00 % 0.46 %

+0.87 (+0.04%)

N/A
IYH iShares U.S. Healthcare E.. 0.00 % 0.43 %

+0.51 (+0.04%)

N/A
JHMH 0.00 % 0.46 %

N/A

N/A
JMIN 0.00 % 0.12 %

N/A

N/A
EVSTC 0.00 % 0.00 %

N/A

N/A
HIG:CA Global Healthcare Income .. 0.00 % 1.02 %

+0.08 (+0.04%)

CAD 0.05B
LS:CA 0.00 % 2.21 %

N/A

N/A
HWF:CA 0.00 % 0.00 %

N/A

N/A
HHL-U:CA Harvest Healthcare Leader.. 0.00 % 0.00 %

+0.03 (+0.04%)

N/A
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

+0.83 (+0.04%)

N/A
VHT Vanguard Health Care Inde.. 0.00 % 0.10 %

+2.30 (+0.04%)

N/A
MIVG:CA Mackenzie Ivy Global Equi.. 0.00 % 0.89 %

-0.08 (0.04%)

CAD 0.02B
IHCU:LSE iShares S&P 500 Health Ca.. 0.00 % 0.00 %

-0.50 (0.04%)

N/A
IUHC:LSE iShares S&P 500 USD Healt.. 0.00 % 0.00 %

-0.06 (0.04%)

USD 2.50B
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

-0.27 (0.04%)

N/A
XDWH:LSE Xtrackers MSCI World Heal.. 0.00 % 0.00 %

-0.11 (0.04%)

N/A
EMWE:F BNP Paribas Easy - MSCI W.. 0.00 % 0.00 %

+0.28 (+0.04%)

N/A
GNAR:F 0.00 % 0.00 %

N/A

N/A
QDVG:F iShares S&P 500 Health Ca.. 0.00 % 0.00 %

+0.12 (+0.04%)

N/A
EWRD:XETRA 0.00 % 0.00 %

N/A

N/A
GNAR:XETRA 0.00 % 0.00 %

N/A

N/A
VMOM:XETRA 0.00 % 0.00 %

N/A

N/A
NUSA:CA NBI Active U.S. Equity ET.. 0.00 % 0.00 %

+0.20 (+0.04%)

CAD 0.07B
XOUT GraniteShares XOUT U.S. L.. 0.00 % 0.00 %

N/A

N/A
BMED BlackRock Future Health E.. 0.00 % 0.00 %

-0.01 (0.04%)

USD 4.16M
HHL-B:CA Harvest Healthcare Leader.. 0.00 % 0.00 %

+0.04 (+0.04%)

N/A
MEDTE:PA BNP Paribas Easy ECPI Glo.. 0.00 % 0.00 %

-0.04 (0.04%)

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 0.00 % 0.00 %

+0.12 (+0.04%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.21% 54% F 34% F
Dividend Return 0.35% 43% F 3% F
Total Return -0.86% 54% F 25% F
Trailing 12 Months  
Capital Gain -0.79% 46% F 34% F
Dividend Return 0.46% 43% F 5% F
Total Return -0.33% 46% F 25% F
Trailing 5 Years  
Capital Gain 68.13% 100% F 80% B-
Dividend Return 3.10% 40% F 8% B-
Total Return 71.23% 100% F 78% C+
Average Annual (5 Year Horizon)  
Capital Gain 8.29% 46% F 61% D-
Dividend Return 8.66% 46% F 55% F
Total Return 0.37% 43% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 29.49% 46% F 36% F
Risk Adjusted Return 29.37% 46% F 44% F
Market Capitalization 54.15B 100% F 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Diagnostics & Research) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 22.10 50% 15%
Price/Book Ratio 3.22 44% 29%
Price / Cash Flow Ratio 23.04 11% 15%
Price/Free Cash Flow Ratio 25.07 22% 13%
Management Effectiveness  
Return on Equity 7.59% 56% 51%
Return on Invested Capital 6.92% 44% 55%
Return on Assets 3.86% 33% 65%
Debt to Equity Ratio 31.24% 63% 72%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.